PER 0.00% 13.5¢ percheron therapeutics limited

Ann: ATL1102 DMD Paediatric Investigation Plan submitted to EMA, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,654 Posts.
    lightbulb Created with Sketch. 797

    My take..

    It's moving and should have approved by the 3rd q max.

    Trials doesn't look likely to start early next year

    No mention of how they are financing obviously I m guessing someone is going to step in now that the plans are submitted and trial design to EMA is next..hence expecting something before that..

    All good. We are going according to the time table provided and next is Partnership...

    DYOR
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.